G Yasuda, D Ando, N Hirawa, S Umemura, O … - Diabetes Care, 2005 - Am Diabetes Assoc Editor's comment: The editorial committee of Diabetes Care had some ethical concerns about
potentially leaving patients for up to 24 weeks with blood pressure between 140/90 and 200/110 mmHg.
After careful consideration, we ... Cited by 11 - Related articles - BL Direct - All 6 versions
L Tylicki, M Renke, P Rutkowski, B … - Medical science monitor: …, 2005 - ncbi.nlm.nih.gov BACKGROUND: Pharmacological blockade of the renin-angiotensin-aldosteron system ameliorates
glomerular and tubulointerstitial damage. For optimal renoprotection, high doses of angiotensin II
converting enzyme inhibitors and ... Cited by 6 - Related articles - All 5 versions
[CITATION] Coronary Angioplasty Amlodipine Restenosis Study. Effects of amlodipine on …
T Ishimitsu, J Minami, M Yoshii, T Suzuki, … - Clinical and …, 2002 - informahealthcare.com Effects of amlodipine (AML), a long-acting calcium antagonist, and losartan (LOS), an angiotensin II
receptor antagonist, on 24-hr blood pressure profile were compared in 15 patients with essential
hypertension. After 4 weeks of ... Cited by 10 - Related articles - BL Direct - All 7 versions
SJ Hong, TN Ahn, SH Baek, WH Cho, HK Jeon, J Kyun, … - Clinical therapeutics, 2006 - Elsevier This multicenter, randomized, double-blind, placebo-controlled, parallel-group study was designed as
a noninferiority study. To be included in the study, previously untreated patients had to have a
sitting diastolic blood pressure ... Cited by 4 - Related articles - All 4 versions
MS Macgregor, CJ Deighan, RSC Rodger, … - Nephron Clinical …, 2005 - content.karger.com Background: Treatment of hypertension slows the progression of non-diabetic
nephropathies, but the optimal regimen is unknown. Angiotensin-converting enzyme inhibitors
are more effective than -blockers, but their merits relative to calcium channel blockers are ... Cited by 5 - Related articles - BL Direct - All 4 versions
S Singh - Clinical cardiology, 1993 - ncbi.nlm.nih.gov The efficacy and tolerability of amlodipine 2.5-10 mg once daily was compared with nadolol 40-160 mg
once daily in a long-term double-blind parallel-group study in patients with stable exertional
angina pectoris. A total of 80 ... Cited by 6 - Related articles
HY Lee, HJ Kang, BK Koo, BH Oh, K Heung-Sun, KS … - Clinical therapeutics, 2005 - Elsevier This was a multicenter, randomized, doubleblind, parallel-group study in which patients received 8
weeks of treatment with either amlodipine adipate or amlodipine besylate. The primary efficacy
variable was noninferiority of the ... Cited by 7 - Related articles - All 4 versions
K Katayama, S Nomura, H Ishikawa, T Murata, S … - Kidney international, 2006 - nature.com Cilnidipine, an L-/N-type calcium channel blocker, dilates the efferent glomerular arterioles in an
experimental model and shows a renoprotective effect, but its clinical benefits and safety have not
yet been assessed in type II ... Cited by 10 - Related articles - BL Direct - All 4 versions
T Ishimitsu, T Kobayashi, T Honda, M Takahashi, J … - Hypertension …, 2005 - nature.com The purpose of this study is to compare the long-term effects of an angiotensin II receptor blocker
(ARB) and a long-acting calcium channel blocker (CCB) on left ventricular geometry, hypertensive
renal injury and a circulating ... Cited by 22 - Related articles - BL Direct - All 4 versions
